“Lovenox (enoxaparin sodium) therapy appears to be safe and efficacious for pregnant women who are candidates for either ...

Twenty-eight obese patients were given once-daily doses of 0.5 mg/kg of enoxaparin sodium, and anti-factor Xa levels were determined after the first or second dose. The investigators found that ...

Purpose. A case of fatal retroperitoneal hematoma that developed after enoxaparin administration in a woman with paroxysmal atrial flutter and chest pain is reported. Summary. A 63-year-old ...

At the end of July, the FDA granted marketing approval to an anticoagulant, the low-molecular-weight heparin (LMWH) enoxaparin sodium injection. The product, co-developed by Momenta ...

Recent data have shown that fondaparinux, a selective factor Xa inhibitor, is noninferior to enoxaparin for short-term prevention of adverse cardiovascular outcomes in patients with non-ST-segment ...